Oramed Pharmaceuticals Inc (ORMP) — Cash Flow Quality Index
Oramed Pharmaceuticals Inc (ORMP) has a Cash Flow Quality Index of -0.08x as of March 2026. Operating cash flow of $-2.92 Million is below net income of $38.31 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Oramed Pharmaceuticals Inc (ORMP) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Oramed Pharmaceuticals Inc Cash Flow Quality Index (2023–2025)
Historical Cash Flow Quality Index for Oramed Pharmaceuticals Inc across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see Oramed Pharmaceuticals Inc (ORMP) cash flow conversion.
Annual Cash Flow Quality Index for Oramed Pharmaceuticals Inc (2023–2025)
Year-by-year earnings quality comparison for Oramed Pharmaceuticals Inc.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | -0.14x | $-9.14 Million | $64.02 Million | ▲ +92.3% |
| 2023 | -1.86x | $-10.29 Million | $5.53 Million | — |